Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Report 2023

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2023 – By Type (Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development And Manufacturing, Secondary Packaging), By Research Phase (Preclinical, Phase I, Phase II, Phase III, Phase IV), By End-User (Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small & Medium-Sized Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 250 | Published : January 2023 | Delivery Time: 2-3 business days | Format :

Need assistance or more information before the purchase?

Enquire Before Buying
Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

Proud Members Of

Pharmaceutical contract development and manufacturing refers to a business that offers services for drug research and manufacture within the pharmaceutical sector. Using CDMOs as a partner, pharmaceutical companies can outsource medication development and production. Full-service drug development and manufacturing outsourcing companies (CDMOs) can handle every stage of the process and work with clients that want to outsource specific steps in their workflow. Everything is based on the requirements of each client.

The main types of pharmaceutical contract development and manufacturing organisations (CMO) are active pharmaceutical ingredient (API) manufacturing, finished dosage formulation (FDF) development and manufacturing, and secondary packaging. The active pharmaceutical ingredient (API) manufacturing includes the manufacturing of the part of any drug that produces the desired effects. The various research phases include preclinical, phase I, phase II, phase III, and phase IV. The different end-use sectors include big pharmaceutical companies, generic pharmaceutical companies, and small & medium-sized pharmaceutical companies.

The global pharmaceutical contract development and manufacturing organisation (CMO) market is segmented -

1) By Type: Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development and Manufacturing, Secondary Packaging

2) By Research Phase: Preclinical, Phase I, Phase II, Phase III, Phase IV

3) By End-User: Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small & Medium-Sized Pharmaceutical Companies

The global pharmaceutical contract development and manufacturing market grew from $122.31 billion in 2022 to $130.82 billion in 2023 at a compound annual growth rate (CAGR) of 7.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The pharmaceutical contract development and manufacturing market is expected to grow from $196.53 billion in 2027 at a CAGR of 10.7%.

The growth of the pharmaceutical contract development and manufacturing market is driven by the increase in the demand for medicines across the globe. The high prevalence of diseases and the need for a longer lifespan increased the demand for medicines pushing the pharmaceutical companies to increase the production of existing drugs and raise the investment in their R&D to promote the development of new drugs. This impels the pharmaceutical companies to collaborate with contract manufacturing organizations (CMOs) as a way to lower operational costs, thus, increasing the demand for pharmaceutical contract development and manufacturing market. According to Alkermes PLC., a biopharmaceutical company indicates that pharmaceutical contract manufacturing will emerge as a strategic option for many companies ranging from very large to smaller specialty pharma entities and this mostly will happen because the pharmaceuticals companies are looking for cost-cutting.

Major players in the pharmaceutical contract development and manufacturing market are Recipharm AB, Pfizer Inc., Boehringer Ingelheim International GmbH, Aenova Group, Famar, Jubilant Life Sciences Limited, Catalent Pharma Solutions, Chemicals Limited, Dishman Pharmaceuticals, HAUPT Pharma AG, Kemwell Pvt. Ltd., Nipro Corp., NextPharma, Royal DSM N.V., Althea Technologies, Thermo Fisher Scientific Inc., Lonza Group Ltd., AbbVie Inc., Consort Medical PLC., Almac Group, Siegfried Holding AG, Evonik Industries AG, and Vetter Pharma International GMBH.

The pharmaceutical contract development and manufacturing market are restricted by the poor-capacity utilization of manufacturing facilities. The capacity utilization is calculated considering the full potential capacity of the production plant. The poor-capacity utilization of the production plant is caused due to the inefficiency of different sub-processes in the production line which results in low production. The low production output results in low revenue generation for the production unit, affecting the overall pharmaceutical contract development and manufacturing market. For instance, in January 2020, according to an article shared by Economic Times, an India-based English-language business-focused daily newspaper, The 1,500 API manufacturing facilities in India, according to the country's drug regulatory organisation, are only operating at 40% of their potential. Therefore, the usage of capacity of the production plant negatively affects the pharmaceutical contract development and manufacturing market.

The companies in the pharmaceutical contract development and manufacturing market are investing in acquiring and forming alliances with other companies in the market. The pharmaceutical contract development and manufacturing companies are following the trend of merger and acquisition to expand their global market reach to meet the client needs, increase their production capabilities while maintaining cost efficiencies, and get access to the latest technology and new services. The high levels of merger and acquisition activities are resulting in the consolidation of the contract service providers. For instance, in July 2022, Pharma Nobis, a US-based provider of contract manufacturing and private label services, acquired Fagron’s U.S. contract manufacturing business for an undisclosed amount. Through this acquisition, Pharma Nobis is expected to offer contract manufacturing and private label services to American retailers and consumer healthcare corporations. 20% of the company will continue to be owned by Fagron.

In August 2022, Catalent, Inc., a US-based provider of delivery technologies, development, and drug manufacturing, acquired Metrics Contract Services for $475 million. This acquisition is expected to improve Catalent's ability to work with highly potent chemicals while enhancing its expertise in integrated oral solid formulation research, production, and packaging to assist clients in streamlining and accelerating their processes. Metrics Contract Services is a US-based pharmaceutical contract development and manufacturing organization.

North America was the largest region in the global pharmaceutical contract development and manufacturing market in 2022. The Middle East is expected to be the fastest growing region in the global pharmaceutical contract development and manufacturing market during the forecast period. The regions covered in the global pharmaceutical contract development and manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the pharmaceutical contract development and manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The pharmaceutical contract development and manufacturing market includes revenues earned by entities by providing drug development and manufacturing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products.

The pharmaceutical contract development and manufacturing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical contract development and manufacturing market statistics, including pharmaceutical contract development and manufacturing industry global market size, regional shares, competitors' pharmaceutical contract development and manufacturing market share, detailed pharmaceutical contract development and manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical contract development and manufacturing industry. This pharmaceutical contract development and manufacturing market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

    Table Of Contents

    1. Executive Summary

    2. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Characteristics

    3. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Trends And Strategies

    4. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market – Macro Economic Scenario

    4.1 COVID-19 Impact On Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    4.2 Ukraine-Russia War Impact On Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    4.3 Impact Of High Inflation On Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    5. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Size And Growth

    5.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Segmentation

    6.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Active Pharmaceutical Ingredient (API) Manufacturing

    Finished Dosage Formulation (FDF) Development And Manufacturing

    Secondary Packaging

    6.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Preclinical

    Phase I

    Phase II

    Phase III

    Phase IV

    6.3. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Big Pharmaceutical Companies

    Generic Pharmaceutical Companies

    Small & Medium-Sized Pharmaceutical Companies

    7. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Regional And Country Analysis

    7.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    8.1. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    9.1. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    9.2. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    10.1. India Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    11.1. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    12.1. Australia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    13.1. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    14.1. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    15.1. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    15.2. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    16.1. UK Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    17.1. Germany Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    18.3. France Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    19.1. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    19.2. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    20.1. Russia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    21.1. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    21.2. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    22.1. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    22.2. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    23.1. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    23.2. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    24.1. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    25.1. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    25.2. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    26.1. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    26.2. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Competitive Landscape And Company Profiles

    27.1. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Competitive Landscape

    27.2. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Company Profiles

    27.2.1. Recipharm AB

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Pfizer Inc.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Catalent Pharma Solutions

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Aenova Group

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Famar

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    29. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: China, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: India, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: UK, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: France, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: North America, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: USA, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: South America, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Recipharm AB Financial Performance
  • Table 28: Pfizer Inc. Financial Performance
  • Table 29: Catalent Pharma Solutions Financial Performance
  • Table 30: Aenova Group Financial Performance
  • Table 31: Famar Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: China, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: India, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: UK, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: France, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: North America, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: USA, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: South America, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Recipharm AB Financial Performance
  • Figure 28: Pfizer Inc. Financial Performance
  • Figure 29: Catalent Pharma Solutions Financial Performance
  • Figure 30: Aenova Group Financial Performance
  • Figure 31: Famar Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report